Scarica l'app Stockscreener
606.74
6.78%
38.51
Dopo l'orario di chiusura:
606.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$568.23
Aprire:
$590.6
Volume 24 ore:
3.31M
Relative Volume:
1.81
Capitalizzazione di mercato:
$232.08B
Reddito:
$42.37B
Utile/perdita netta:
$6.14B
Rapporto P/E:
38.04
EPS:
15.95
Flusso di cassa netto:
$7.78B
1 W Prestazione:
+5.55%
1M Prestazione:
+16.94%
6M Prestazione:
-1.35%
1 anno Prestazione:
+6.99%
Intervallo 1D:
$590.00
$610.97
Intervallo di 1 settimana:
$566.70
$610.97
Portata 52W:
$493.30
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
606.74 | 232.08B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
223.08 | 160.42B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
151.38 | 42.01B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
201.78 | 36.62B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
423.99 | 34.72B | 3.84B | 866.24M | 792.60M | 10.37 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific Gaps Up, Nearing A Buy Point, On Strong Earnings Beat - MSN
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Scientific Gaps Up And Nears A Buy Point On Strong Earnings Beat - Investor's Business Daily
Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates - Yahoo Finance
Thermo Fisher Scientific (TMO) Q4 2024 Earnings Call Transcript - AOL
New products drive Thermo Fisher earnings - 69News WFMZ-TV
Thermo Fisher Stock Surges 6.6% as Q4 Earnings Smash Estimates--Can It Keep the Momentum in 2025? - Yahoo Finance
Thermo Fisher Stock Surges as Medical Device Maker's Results Top Estimates - Investopedia
Thermo Fisher CEO: 'We'll manage through' Trump policy changes - The Business Journals
Thermo Fisher Q4 Earnings and Revenues Top Estimates, Stock Up - Yahoo Finance
Thermo Fisher sees robust 2025 profit on improved demand for its tools and services - Reuters
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Bought by Manning & Napier Advisors LLC - MarketBeat
Thermo Fisher stock higher after Q4 beat (TMO:NYSE) - Seeking Alpha
Earnings call transcript: Thermo Fisher Scientific beats Q4 2024 forecasts - Investing.com
Thermo Fisher (TMO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands - Benzinga
Thermo Fisher Scientific beats Q4 estimates, shares rise - MSN
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by New England Research & Management Inc. - MarketBeat
Raymond James maintains Thermo Fisher Outperform, $650 target - Investing.com India
Why Thermo Fisher Scientific (TMO) Is the Best Stock to Buy in 2025 for Beginners - Yahoo Finance
Thermo Fisher Exceeds Q4 Earnings Expectations and Revenue TargetsNews and Statistics - IndexBox, Inc.
Thermo Fisher Scientific (TMO) Q4 Earnings and Revenues Top Estimates - Yahoo Finance Australia
Thermo Fisher Tops Estimates With Strong Demand In Therapy Development - Finimize
Thermo Fisher Scientific Exceeds Q4 2024 Expectations with $4.78 EPS and $11.40 Billion Revenue - GuruFocus.com
Thermo Fisher beats quarterly estimates on strong demand for its tools and services -January 30, 2025 at 06:52 am EST - Marketscreener.com
Thermo Fisher Sees Robust 2025 Profit on Improved Demand for Its Tools and Services - U.S News & World Report Money
Thermo Fisher Scientific Profit, Revenue Rose in 4Q - MarketWatch
Thermo Fisher Scientific earnings beat by $0.15, revenue topped estimates - Investing.com Canada
Thermo Fisher: Q4 Earnings Snapshot -January 30, 2025 at 06:19 am EST - Marketscreener.com
Thermo Fisher: Q4 Earnings Snapshot - Milton Daily Standard
Thermo Fisher Scientific's Q4 Adjusted Earnings, Revenue Rise -January 30, 2025 at 06:10 am EST - Marketscreener.com
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results - The Bakersfield Californian
Oligonucleotide CDMO Global Market Report 2025, with - GlobeNewswire
Is Thermo Fisher Scientific Inc. (TMO) the Safe Stock to Buy for the Long Term in 2025? - Insider Monkey
Thermo Fisher considering moving operations; negotiations underway with Middleton, state - WKOW
Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market - MarketWatch
Robeco Institutional Asset Management B.V. Acquires 30,758 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Q4 2024 Earnings Preview - MSN
Smart Money Is Betting Big In TMO Options - Benzinga
Single Use Assemblies Market Global Forecasts to 2029: Rapid Growth in Single-Use Assemblies Market Driven by Biologics and Biosimilars Demand - GlobeNewswire Inc.
Earnings Preview: Thermo Fisher Is Facing Way Too Many Headwinds (NYSE:TMO) - Seeking Alpha
Orrstown Financial Services Inc. Has $659,000 Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Swedbank AB Acquires 228,475 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Forsta AP Fonden Cuts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Hantz Financial Services Inc. Reduces Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
McKinley Carter Wealth Services Inc. Sells 562 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Emission Monitoring System Market 2025 Industry Analysis, Top - openPR
Celiac Disease Testing Market Statistical Forecast, Trade - openPR
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Pacer Advisors Inc. - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Blue Trust Inc. - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Kingswood Wealth Advisors LLC - MarketBeat
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
2.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):